Insider Transactions Reported by 20 Insiders of MAXCYTE, INC.

Symbol
MXCT on Nasdaq
Location
Rockville, MD

Insiders trading volume in the past year

MAXCYTE, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Casdin Partners Master Fund, L.P. 10%+ Owner $45,300,000 03 Oct 2022
Art Mandell Director $1,940,066 11 Jun 2024
Douglas Doerfler President and CEO, Director $1,509,382 04 Dec 2023
Stanley C. Erck Director $546,585 +$137,220 +34% 13 Aug 2025
J. Stark Thompson PhD Director $502,459 09 Aug 2021
John Joseph Johnston Director $407,360 18 Jun 2025
DOUGLAS RICHARD Director $320,040 +$111,040 +53% 13 Aug 2025
Maher Masoud President and CEO, Director $240,135 +$102,915 +75% 13 Aug 2025
Douglas J. Swirsky Chief Financial Officer $208,736 +$64,500 +45% 13 Aug 2025
David I. Sandoval General Counsel $204,171 18 Mar 2025
William W. Brooke Director $194,633 +$64,500 +50% 13 Aug 2025
Cynthia Collins Director $192,515 18 Jun 2025
Ali Soleymannezhad Chief Commercial Officer $188,974 18 Mar 2025
Patrick J. Balthrop Director $120,373 18 Jun 2025
B. al Wakeel Director $120,373 18 Jun 2025
Thomas M. Ross Evp, Global Sales $109,025 01 Aug 2024
Rekha Hemrajani Director $83,555 -$22,378 -21% 25 Jun 2025
Cenk Sumen Chief Scientific Officer 11 Apr 2022
Ron Holtz Chief Financial Officer 20 Mar 2023
Amanda Louise Murphy Chief Financial Officer 25 Mar 2022

Recent Insider Transactions by Companies or Individuals for MAXCYTE, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Douglas J. Swirsky MXCT Common Stock Purchase 44.7% $64,500 $1.29 50,000 161,811 13 Aug 2025 Direct
Maher Masoud MXCT Common Stock Purchase 75% $102,915 $1.37 75,000 175,000 13 Aug 2025 Direct
Stanley C. Erck MXCT Common Stock Purchase 33.5% $137,220 $1.37 100,000 398,328 13 Aug 2025 Direct
Douglas Richard MXCT Common Stock Purchase 53.1% $111,040 $1.39 80,000 230,577 13 Aug 2025 Direct
William W. Brooke MXCT Common Stock Purchase 49.6% $64,500 $1.29 50,000 150,879 13 Aug 2025 Direct
Rekha Hemrajani MXCT Common Stock Sale -21.1% $22,378 $2.09 -10,684 39,893 25 Jun 2025 Direct
John Joseph Johnston MXCT Common Stock Award 20.6% 29,210 171,160 18 Jun 2025 Direct
John Joseph Johnston MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
Rekha Hemrajani MXCT Common Stock Award 136.7% 29,210 50,577 18 Jun 2025 Direct
Rekha Hemrajani MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
Stanley C. Erck MXCT Common Stock Award 10.8% 29,210 298,328 18 Jun 2025 Direct
Stanley C. Erck MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
Douglas Richard MXCT Common Stock Award 24.1% 29,210 150,577 18 Jun 2025 Direct
Douglas Richard MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
Cynthia Collins MXCT Common Stock Award 56.5% 29,210 80,889 18 Jun 2025 Direct
Cynthia Collins MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
William W. Brooke MXCT Common Stock Award 40.8% 29,210 100,879 18 Jun 2025 Direct
William W. Brooke MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
Patrick J. Balthrop MXCT Common Stock Award 136.7% 29,210 50,577 18 Jun 2025 Direct
Patrick J. Balthrop MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
B. al Wakeel MXCT Common Stock Award 136.7% 29,210 50,577 18 Jun 2025 Direct
B. al Wakeel MXCT Stock Option (right to buy) Award 50,790 50,790 18 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.